Publications by authors named "Emily Botto"

Claim this Profile
T
Trends in the Burden for Patients Participating in Industry-Funded Clinical Trials.
Abigail Dirks, Emily Botto, Zachary Smith, Kenneth Getz

Ther Innov Regul Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinical Research Interaction Scale for Racial and Ethnic Minority Participants.
Jennifer Y Kim, Emily Botto, Ruby Madison Ford

JAMA Netw Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of socioeconomic status on individual attitudes and experience with clinical trials.
Jennifer Y Kim, Maria Florez, Emily Botto, Xoli Belgrave, Clare Grace

Commun Med (Lond)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Benchmarks on Protocol Amendment Experience in Oncology Clinical Trials.
Emily Botto, Zachary Smith, Kenneth Getz

Ther Innov Regul Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping Strategies for Reaching Socioeconomically Disadvantaged Populations in Clinical Trials.
Maria I Florez, Emily Botto, Jennifer Y Kim

JAMA Netw Open· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Benchmarks on Protocol Amendment Practices, Trends and their Impact on Clinical Trial Performance.
Kenneth Getz, Zachary Smith, Emily Botto, Elisabeth Murphy, Arnaud Dauchy

Ther Innov Regul Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Benchmarks on Demographic Disparities in Pivotal Trials Supporting FDA-Approved Drugs and Biologics.
Zachary Smith, Emily Botto, Otis Johnson, Todd Rudo, Kenneth Getz

Ther Innov Regul Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is hindering the drug development industry from achieving diversity, equity and inclusion in its workforce?
Jennifer Y Kim, Emily Botto

Nat Biotechnol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights from a Multi-company Workshop to Apply a Patient Participation Burden Algorithm to Protocol Data.
Zachary Smith, Emily Botto, Christopher Carney, Abhishek Bagga, Bazgha Qutab

Ther Innov Regul Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying Diversity and Representation in Pivotal Trials Leading to Marketing Authorization in Europe.
Zachary Smith, Emily Botto, Kenneth Getz

Ther Innov Regul Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Investigative Site Personnel Diversity and Its Relationship with Study Participant Diversity.
Kenneth Getz, Maria Florez, Emily Botto, Kim Ribeiro, Gretchen Goller

Ther Innov Regul Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis